<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nine years after receiving a bone marrow transplant for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, a 14-year-old girl with severe <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">pulmonary disease</z:e> associated with <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> received a double lung transplant </plain></SENT>
<SENT sid="1" pm="."><plain>Subsequent to lung transplant, her lung function improved dramatically (FEV1 increasing from 20 to 73 percent predicted <z:mpath ids='MPATH_458'>normal</z:mpath>, residual volume decreasing from 316 to 130 percent predicted <z:mpath ids='MPATH_458'>normal</z:mpath> values) </plain></SENT>
<SENT sid="2" pm="."><plain>The patient is currently well 15 months after transplant, while receiving immunosuppression consisting of FK506 and <z:chebi fb="2" ids="2948">azathioprine</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Double lung transplantation may offer a therapeutic option for the treatment of graft-versus-host <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">pulmonary disease</z:e> in selected patients </plain></SENT>
</text></document>